HCW Biologics lowers shareholder meeting quorum to 33.3% voting power

• HCW Biologics adopted bylaw amendment lowering shareholder meeting quorum to 33 1/3% of voting power.
• Change takes effect April 28, 2026.
• New threshold counts voting power present in person or by proxy, including proxies without authority to vote on any matter.
• Previous bylaws required majority of outstanding voting power entitled to vote to constitute quorum.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-017099), on April 16, 2026, and is solely responsible for the information contained therein.